Advertisement Meridian Bioscience signs new Canadian distribution agreement with Somagen - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Meridian Bioscience signs new Canadian distribution agreement with Somagen

Meridian Bioscience, a fully integrated life science company, has signed a new exclusive Canadian distribution agreement with Somagen Diagnostics, Edmonton, Alberta. This decision is consistent with Meridian's stated commitment to expand its non-US businesses.

Jack Kraeutler, CEO of Meridian Bioscience, said: “The effective global distribution of our rapid tests for infectious disease is one of Meridian’s key strategies. By working closely with the ideal partner, Somagen Diagnostics, the Canadian market provides both of our companies with many opportunities for accelerated long-term growth.”

Kevin Blackburn, president of Somagen Diagnostics, said: “Somagen is very excited to add the Meridian Bioscience family of products to its portfolio in Canada and looks forward to serving all of the needs in the microbiology and infectious disease testing area of the laboratory.”